1 month VRTX Down as Non-Opioid Drug Shows Similar Pain Reduction as Placebo Zacks

Vertex announces data from a phase II study evaluating its NaV1.8 pain signal inhibitor, suzetrigine, for treating painful lumbosacral radiculopathy. Shares down.